HealthDay News — Levetiracetam performs better than carbamazepine and lamotrigine for individuals with partial seizures, according to a review and meta-analysis published online June 29 in the ...

Eisai announced that the FDA has approved Fycompa (perampanel tablets) as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy ...

Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...

The FDA recently approved XCOPRI for adults with partial-onset seizures, its manufacturer announced. “The approval of XCOPRI will provide clinicians with an effective medication for our patients who ...

Partial seizures are the most common seizure type in children. New antiepileptic drugs are needed because current treatments are often inadequate, or have intolerable adverse effects. Levetiracetam ...

Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...

The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating partial-onset seizures among children as young as 1 month. “When a child or infant ...

This review contrasts the standard of care for focal epilepsy with the complex reality of managing non-lesional and ...

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...

If your child has a seizure, it's natural to have plenty of concerns about what exactly happened, why, and what comes next. There are treatments that can help, but a lot depends on the cause of the ...